Table 4: Lab results of INDEN ambulatory patients, 2018.
|
Total Population n = 500 |
Male n = 221 (44.2%) |
Female n = 279 (55.8%) |
P-value |
Fasting Blood Glucose < 100 100-125 > 125 |
(n = 373) 75 (20.11%) 99 (26.54%) 199 (53.35%) |
(n = 151) 28 (18.54%) 36 (23.84%) 87 (57.62%) |
(n = 222) 47 (21.17%) 63 (28.38%) 112 (50.45%) |
0.3924 |
Non-Fasting Blood Glucose < 200 > 200 |
(n = 459) 327 (71.24%) 132 (28.76%) |
(n = 200) 136 (68.00%) 64 (32.00%) |
(n = 259) 191 (73.75%) 68 (26.25%) |
0.1775 |
HbA1c < 7% ≥ 7% |
(n = 354) 139 (39.27%) 215 (60.73%) |
(n = 150) 46 (30.67%) 104 (69.33%) |
(n = 204) 93 (45.59%) 111 (54.41%) |
0.0045 |
Total cholesterol Optimal Borderline High High |
(n = 358) 217 (60.61%) 82 (22.91%) 59 (16.48%) |
(n = 153) 102 (66.67%) 33 (21.57%) 18 (11.76%) |
(n = 205) 115 (56.10%) 49 (23.90%) 41 (20.00%) |
0.0663 |
HDL Optimal Borderline Low Low |
(n = 337) 41 (12.17%) 169 (50.15%) 127 (37.69%) |
(n = 139) 17 (12.23%) 55 (39.57%) 67 (48.20%) |
(n = 198) 24 (12.12%) 114 (57.58%) 60 (30.30%) |
0.0022 |
LDL Optimal Near Optimal Borderline High High Very High |
(n = 341) 122 (35.78%) 102 (29.91%) 67 (19.65%) 29 (8.50%) 21 (6.16%) |
(n = 141) 64 (45.39%) 39 (27.66%) 22 (15.60%) 8 (5.67%) 8 (5.67%) |
(n = 200) 58 (29.00%) 63 (31.50%) 45 (22.50%) 21 (10.50%) 13 (6.50%) |
0.0268 |
Triglycerides Optimal Borderline High High Very High |
(n = 353) 218 (61.76%) 68 (19.26%) 62 (17.56%) 5 (1.42%) |
(n = 149) 93 (62.42%) 27 (18.12%) 26 (17.45%) 3 (2.01%) |
(n = 204) 125 (61.27%) 41 (20.10%) 36 (17.65%) 2 (0.98%) |
0.8390 |
Hemoglobin Low Normal High |
(n = 308) 90 (29.22%) 214 (69.48%) 4 (1.30%) |
(n = 129) 43 (33.33%) 84 (65.12%) 2 (1.55%) |
(n = 179) 47 (26.26%) 130 (72.63%) 2 (1.12%) |
0.3676 |
White blood cells Low Normal High |
(n = 254) 2 (0.79%) 216 (85.04%) 36 (14.17%) |
(n = 108) 1 (0.93%) 96 (88.89%) 11 (10.19%) |
(n = 146) 1 (0.68%) 120 (82.19%) 25 (17.12%) |
0.2892 |
HbA1c: Hemoglobin A1c; HDL: High-Density Lipoprotein; LDL: Low-Density Lipoprotein.